Home  /  Resource Library  /  Real-world effectiveness of zanubrutinib plus salvage chemotherapy in relapsed or refractory double-expressor DLBCL

Real-world effectiveness of zanubrutinib plus salvage chemotherapy in relapsed or refractory double-expressor DLBCL

Real world study of zanubrutinib combined with chemotherapy for treatment of relapsed DLBCL.